FDA authorizes Abbott's wearable to monitor ketone and glucose in diabetes patients
The biowearable is designed to alert people of rising ketones that can lead to a diabetic ketoacidosis (DKA) emergency, a serious health complication for people with diabetes
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.thehindu.com — the content belongs to The Hindu - Sci-Tech.
